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INTRODUCTION
In the renin-angiotensin-aldosterone systems, angiotensin
II is well known to mediate progressive renal disease not only
by elevating glomerular pressure, but also by non-hemody-
namic effects on the kidney, such as proliferation of renal cells
including mesangial cells, recruitment of mononuclear cells
into the kidney by NF-κ B-mediated transcription of chemo-
kines, and stimulating renal TGF-β , fibronectin and type I
collagen expression (1, 2). Angiotensin converting enzyme
inhibitors and angiotensin receptor blockers have shown
efficacy in slowing the progression of diabetic and non-dia-
betic renal disease as well as in decreasing proteinuria (1). 
Recently, emerging and convincing evidences have shown
the independent role of aldosterone in the progression of renal
disease. In the remnant kidney model using rat, aldosterone
induced proteinuria, hypertension and glomerulosclerosis
(3). In addition, inhibition of aldosterone by spironolactone
not only slowed the development of glomerulosclerosis, but
also induced the regression of existing glomerulosclerosis in
the same model (4). Aldosterone infusion developed malig-
nant nephrosclerosis in saline-drinking stroke-prone hyper-
tensive rats, independent of the effects of blood pressure (5)
and induced severe inflammation and fibrosis by macrophage
infiltration and cytokine up-regulation in saline-drinking
rats (6).
The role of TGF-βin the aldosterone-induced renal injury
has been suggested in animal models of various renal diseases.
In a rat model of chronic cyclosporine A (CsA) nephrotoxic-
ity, spironolactone treatment reduced arteriolopathy and tubu-
lointerstitial fibrosis by prevention of CsA-induced up-reg-
ulation of TGF-β , collagen I and fibronectin (7), and also
prevented the progression of renal injury in preexisting chron-
ic CsA nephrotoxicity (8). Aldosterone also played a role in
diabetic renal injury, which was demonstrated by increasing
glomerular and tubulointerstitial macrophage infiltration,
plasminogen activator inhibitor-1 and TGF-βexpression in
streptozotocin-induced diabetic rats (9), and by increasing
renal tissue and urinary levels of monocyte chemoattractant
protein-1 as well as renal macrophage infiltration in type 2
diabetic rats (10). Juknevicius and colleagues demonstrated
that aldosterone infusion for 3 days in normal rats increased
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Aldosterone-induced TGF-β β 1 Expression is Regulated by Mitogen-
Activated Protein Kinases and Activator Protein-1 in Mesangial Cells
Aldosterone has been shown to stimulate renal TGF-β 1 expression. However, the
mechanisms for aldosterone-induced TGF-β 1 expression have not been clearly
determined in mesangial cells. We examined the role of extracellular-signal regu-
lated kinase 1 and 2 (ERK1/2), c-Jun N-terminal kinase (JNK) and activator pro-
tein-1 (AP-1) in the aldosterone-induced TGF-β 1 expression in rat mesangial cells.
TGF-β 1 protein in the conditioned medium released from rat mesangial cells was
measured by sandwich ELISA, TGF-β 1 mRNA expression was analyzed by North-
ern blotting, AP-1 DNA binding activity was measured by EMSA and the ERK1/2,
JNK activity was analyzed by western blotting. Aldosterone significantly stimulated
TGF-β 1 protein production and TGF-β 1 mRNA expression in mesangial cells in a
dose-dependent manner. Aldosterone significantly increased AP-1 DNA binding
activity in mesangial cells. Pre-treatment of cells with AP-1 inhibitor, curcumin, block-
ed aldosterone-induced AP-1 DNA binding activity as well as aldosterone-induced
TGF-β 1 production. Aldosterone increased phosphorylation of ERK1/2 and JNK in
mesangial cells. Pre-treatment of cells with ERK1/2 inhibitor, PD98059, or JNK inhi-
bitor, SP600125 significantly inhibited aldosterone-induced ERK1/2 and JNK activi-
ty and subsequently TGF-β 1 production, respectively. We conclude that aldosterone-
induced TGF-β 1 expression in mesangial cells is regulated by the ERK1/ 2, JNK and
AP-1 intracellular signaling pathways.
Key Words : Aldosterone; Transforming Growth Factor beta1; Extracellular Signal-Regulated MAP Kinases;
JNK Mitogen-Activated Protein Kinases; Transcription Factor AP-1
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Accepted : 17 December 2008urinary TGF-βexcretion without changes in blood pressure
or evidence of kidney damage (11).
The renal protective effects of inhibiting aldosterone were
also demonstrated in chronic kidney disease patients. In a
prospective randomized open-label study, spironolactone treat-
ment for 1 yr in patients with chronic kidney disease already
treated with angiotensin-converting enzyme inhibitors and/
or angiotensin type 1 receptor antagonists significantly dec-
reased proteinuria without any change in glomerular filtra-
tion rate (12). Similar results were observed in another clin-
ical study (13). 
Putting these results from various experimental studies to-
gether, it is positive that aldosterone stimulates renal TGF-β
expression in the course of progressive renal injury. Recent-
ly, Han et al. (10) described the aldosterone stimulated NF-
κ B DNA binding activity and subsequently monocyte che-
moattractant protein-1 expression in mesangial cells. How-
ever, it has not been clearly determined if aldosterone-induced
TGF-β expression was mediated through the extracellular-sig-
nal regulated-kinase 1 and 2 (ERK1/2), c-Jun N-terminal
kinase (JNK) and activator protein-1 (AP-1) pathways in me-
sangial cells. In this study, we examined the role of ERK1/2,
JNK and activator protein-1 in the intracellular signaling
pathways of aldosterone-induced TGF-β 1 expression in rat
mesangial cells. 
MATERIALS AND METHODS
Reagents
Recombinant human TGF-β 1 and anti-human TGF-β 1
antibodies were purchased from R&D Systems (Minneapo-
lis, MN, U.S.A.). Anti-c-Jun antibody, anti-c-Fos antibody
and AP-1 consensus oligonucleotides (5′ -CGC TTG ATG
ACT CAG CCG GAA-3′ ) were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, U.S.A.). JNK and ERK1/2
antibodies were purchased from Cell Signaling Technology
(Beverly, MA, U.S.A.). The [32P]dCTP and [γ -32P]ATP were
obtained from NEN (Boston, MA, U.S.A.). Aldosterone, cur-
cumin and spironolactone were purchased from Sigma-Aldrich
(Deisenhofen, Germany). PD98059 was purchased from Cal-
biochem (Darmstadt, Germany). SP600125 was purchased
from Biomol Research Laboratories (Plymouth Meeting, PA,
U.S.A.). All supplements for cell culture were purchased from
Life Technologies (Gaithersburg, MD, U.S.A.). 
Cell culture 
Rat mesangial cells were isolated from glomeruli of nor-
mal renal cortex as described previously (14). Mesangial cells
were grown in RPMI1640 medium supplemented with 10%
heat-inactivated FBS, 10 mM HEPES, and an antibiotic/anti-
fungal solution. 
TGF-β β 1 ELISA
After a 24 hr starvation, confluent cells were stimulated with
aldosterone (0.2 ng/mL, 1 ng/mL, 5 ng/mL) for 24 hr. The
conditioned medium was collected, centrifuged at 10,000 xg
(4℃) for 3 min and stored at -70℃ until assayed. For the
time course, confluent cells incubated in the serum free medi-
um were incubated with or without aldosterone (5 ng/mL) for
the indicated time points. For TGF-β 1 ELISA, the conditioned
medium was incubated with 1N HCl for 60 min to activate
latent TGF-β 1, and then neutralized with 1N NaOH. Anti-
TGF-β 1 Ab (1 μ g/mL) and biotinylated Anti-TGF-β 1 Ab
(300 ng/mL) were used. The TMB microwell peroxidase sub-
strate system (Kirkegaard & Perry Laboratories, Gaithers-
burg, MD, U.S.A.) was used as an enzyme substrate and the
reaction was followed by measurement of OD450.
Isolation of RNA and TGF-β β 1 Northern blot analysis
Serum-starved confluent cells were stimulated with aldos-
terone (5 ng/mL) for the indicated time points. RNA was
isolated by one-step guanidium-thiocyanatephenol-chloro-
form extraction. RNA quantification was determined by
absorbance at 260 nm. Total RNA was fractionated by elec-
trophoresis on a 1% agarose-formaldehyde gel, blotted by
capillary transfer on a nylon membrane (Gene Screen; NEN,
Boston, MA, U.S.A.), and cross-linked by UV irradiation
(UV Strata-linker 1800; Stratagene, La Jolla, CA, U.S.A.).
The membrane was probed with rat TGF-β 1 cDNA labeled
by random priming using a commercial kit (Amersham,
Buckinghamshire, U.K.) and [32P]dCTP. The blot was pre-
hybridized at 42℃ for 2 hr in 50% formamide, 0.1% SDS,
2×Denhardt’s solution, 5×standard SSPE, and 0.1 mg/mL
salmon sperm DNA. Probe (106 cpm/mL) was added to the
prehybridization solution, and the blot was hybridized over-
night at 42℃. The blot was then washed twice for 10 min
each at 55℃ in 2×standard saline citrate and 0.1% SDS,
and autoradiography was performed with Fuji radiograhpy
film (Tokyo, Japan) and an intensifying screen at -70℃. The
rat TGF-β 1 probe was then removed by boiling, and the
same blot was rehybridized to a cDNA probe encoding for
the GAPDH. The intensity of the blots was quantified by
densitometric analysis.
Electrophoretic mobility shift assay (EMSA)
Confluent cells were starved for 24 hr and then were stimu-
lated with aldosterone (5 ng/mL) for 15 min. Nuclear extracts
were prepared from the treated cells that were pelleted (-500
xg, 10 min, 4℃) and resuspended in hypotonic buffer (10
mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM
EGTA, 1 mM DTT, 0.5 mM PMSF, complete protease inhib-
it mixture tablets) and incubated for 10 min on ice. Cells were
lyzed by the addition of Nonidet P-40 (final concentration
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buffer (20 mM HEPES, pH 7.9, 0.4 mM KCl, 1 mM EDTA,
1 mM EGTA, 1 mM DTT, 1 mM PMSF, complete protease
inhibit mixture tablets) and incubated for 10 min on ice, and
the tubes were centrifuged at 14,000 xg (4℃) for 10 min.
The supernatants were stored at -70℃ until used. The pro-
tein content in nuclear extracts was measured by the Brad-
ford method (Bio-Rad, Hercules, CA, U.S.A.). The oligonu-
cleotide containing the AP-1 consensus binding sequence
was radiolabeled with [γ -32P]ATP by T4 polynucleotide kinase
(Roche, Mannheim, Germany) for 30 min at room temper-
ature. Unincorporated label was removed with a Chroma
spin STE-10 column (Clontech Laboratories, Palo Alto, CA,
U.S.A.). The binding reaction was performed for 30 min at
room temperature in a total volume of 20 μ L containing bind-
ing buffer (50 mM Tris, pH 7.5, 250 mM NaCl, 2.5 mM
EDTA, 20% glycerol, 2.5 mM DTT, and 5 mM MgCl2), 5
μ g of nuclear protein extracts, 1 μ L of 32P-labeled oligonu-
cleotide, and 50 μ g/mL poly (dI-dC) (Roche). The DNA-
protein complexes were fractionated by electrophoresis over
6% polyacrylamide gels in 1x Tris-boric acid-EDTA buffer.
The gels were dried and exposed to radiograhy film for autora-
diography.
Western blot analysis
Confluent cells were starved for 24 hr and then were stim-
ulated with aldosterone (5 ng/mL) for 10 min. The treated
cells were lyzed for 10 min on ice in lysis buffer (50 mM Tris,
pH 7.5, 40 mM NaCl, 1% Triton X-100, 2 mM EDTA, 1
μ g/mL leupeptin, 2 mM DTT, and 1 mM PMSF). Lysates
were cleared by centrifugation at 14,000 xg(4℃) for 10 min.
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Fig. 1. Aldosterone stimulates TGF-β 1 production in mesangial cells. (A) Mesangial cells were incubated with or without aldosterone (5 ng/
mL) for the indicated time points (   , untreated:    , treated with aldosterone). *p<0.05 vs. untreated control. (B) Cells were incubated with
various dose of aldosterone or angiotensin II (10
-7 M) or a combination of aldosterone and angiotensin II for 24 hr. *p<0.05 vs. untreated
control. 
� p<0.05 vs. angiotensin II-treated cells. (C) Cells were pre-incubated with or without spironolactone (10
-9 M) for 60 min and then
incubated with aldosterone (5 ng/mL) for 16 hr. *p<0.05 vs. untreated control. 
� p<0.05 vs. aldosterone-treated cells. In all of (A), (B) and
(C) TGF-β 1 protein was measured by ELISA. Results from 5 independent experiments are shown as mean±SEM. (D) TGF-β 1 protein
expression was measured by western blot analysis after cells were pre-incubated with or without spironolactone (10
-9 M) for 60 min, and
then incubated with aldosterone. *p<0.01 vs. untreated control. 
� p<0.05 vs. aldosterone-treated cells. 
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CTotal protein was quantified by the Bradford method. Equal
amounts of lysates were fractionated by 10% SDS-PAGE
and electrotransferred to Bio-Blot nitrocellulose membranes
(Bio-Rad). The membranes were blocked with TBS (pH 7.6)/
5% nonfat dry milk/0.05% Tween 20, and were blotted with
the indicated antibodies at 4℃ overnight. The membranes
were incubated with 1/1,000 diluted HRP-conjugated sec-
ondary antibody (Amersham) at room temperature for 1 hr
and visualized by an ECL kit (Amersham). The membranes
were stripped in solution (62.5 mM Tris-HCl, pH 7.5, 20
mM DTT, and 1% SDS) for 5 min at 50℃ with agitation
and reprobed with anti-total JNK or anti-total ERK1/2 anti-
body.
Statistical analysis
Data were expressed as the mean±SEM. Statistical com-
parisons between multiple groups were performed by ANO-
VA and Bonferroni’s method was applied to control for mul-
tiple testing. Statistical comparisons between multiple time
points were performed by repeated measure ANOVA, with
a minimum value of p<0.05 considered to represent statisti-
cal significance.
RESULTS
Aldosterone Stimulates TGF-β β 1 Production 
TGF-β 1 protein was measured in the supernatants of rat
mesangial cells stimulated with aldosterone (5 ng/mL) by
ELISA. TGF-β 1 was constitutively produced by rat mesangial
cells and was stimulated by aldosterone, which was statistical-
ly significant at 24 hr and 48 hr (n=5, p<0.05; Fig. 1A). We
then measured TGF-β 1 protein in the supernatants of cells
incubated with various concentration of aldosterone with or
without angiotensin II (10-7 M) for 24 hr. Aldosterone stim-
ulated TGF-β 1 production in a dose-dependent manner. An-
giotensin II also stimulated TGF-β 1 production as previously
described in the same cells (15). Furthermore, a combina-
tion treatment of the cells with aldosterone and angiotensin
II additively stimulated TGF-β 1 production significantly
more than single treatment (n=5, p<0.05; Fig. 1B). To deter-
mine if the mineralocorticoid receptor mediates the aldos-
terone-induced TGF-β 1 production, cells were pre-incubat-
ed with or without spironolactone (10-9 M) for 60 min and
then stimulated with aldosterone (5 ng/mL) for 24 hr. Spirono-
lactone abolished aldosterone-induced TGF-β 1 production
(n=5, p<0.05, Fig. 1C).
We also examined the TGF-β 1 protein expression in the
lysates of cells, which were stimulated with aldosterone for
24 hr by western blot analysis. Aldosterone significantly
stimulated TGF-β 1 protein expression in a dose-dependent
manner, which was blocked by pre-incubation of cells with
spironolactone (10-9 M) (n=5, p<0.01, Fig. 1D). 
Aldosterone stimulates TGF-β β 1 mRNA expression 
We measured TGF-β 1 mRNA in the cells incubated with
various concentration of aldosterone with or without angio-
tensin II (10-7 M) for 16 hr. Aldosterone significantly stimu-
lated TGF-β 1 mRNA expression in a dose-dependent manner.
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Fig. 2. Aldosterone stimulates TGF-β 1 mRNA expression in mesangial cells. (A) Cells were incubated with various dose of aldosterone (5 ng/
mL) or angiotensin II (10
-7 M) or a combination of aldosterone and angiotensin II for 16 hr. *p<0.05 vs. untreated control. 
� p<0.05 vs. angiotensin
II-treated cells. (B) Cells were pre-incubated with or without spironolactone (10
-9 M) for 60 min and then incubated with aldosterone (5 ng/mL)
for 16 hr. *p<0.05 vs. untreated control. 
� p<0.05 vs. aldosterone-treated cells. In both (A) and (B), Upper panel, the autoradiograph is a
representative of five independent experiments with similar results. Lower panel, the optical density of autoradiographic signals was quanti-
fied and calculated as the ratio of TGF-β 1 to GAPDH mRNA. Results are expressed as fold increase over untreated (represented as 1) in
densitometric arbitrary units. Each value represents the mean±SEM. 
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�A combination treatment of the cells with aldosterone and
angiotensin II additively stimulated TGF-β 1 mRNA expres-
sion significantly more than single treatment (n=5, p<0.05,
Fig. 2A). When cells were pre-incubated with spironolactone
(10-9 M) for 60 min and then stimulated with aldosterone (5
ng/mL) for 16 hr, aldosterone-induced TGF-β 1 mRNA expres-
sion was abolished (n=5, p<0.05, Fig. 2B).
Role for AP-1 activation in the aldosterone-induced TGF-
β β 1 expression
The 5′ -flanking sequences of rat TGF-β 1 gene contains
AP-1 binding site (16), suggesting a potential role for AP-1
in the regulation of TGF-β 1 expression. However, it has not
been clearly determined whether aldosterone stimulates AP-
1 activity and whether aldosterone-induced AP-1 activity
triggers TGF-β 1 expression in mesangial cells. Therefore, we
examined AP-1 activity in rat mesangial cells stimulated with
aldosterone by EMSA using AP-1 consensus oligonucleotides.
AP-1 DNA binding activity was significantly increased by
aldosterone (5 ng/mL), which was maximal at 15 min (n=5,
p<0.05, Fig. 3A). Supershift analysis indicated that the AP-
1 complexes induced by aldosterone contained c-Jun and c-
Fos proteins (Fig. 3B). The specificity of the AP-1 binding
activity was tested using both an unlabelled consensus AP-1
oligonucleotiedes (cold probe) and a mutant AP-1 oligonu-
cleotides, which has two base changes within the AP-1 bind-
ing motif (CA to TG), at the same molar quantity (50-fold
excess) for competition. The specific band induced by aldos-
terone was deleted by preincubation of nuclear extracts with
excessive amounts of unlabelled AP-1 oligonucleotides, but
not by preincubation of nuclear extracts with mutant AP-1
oligonucleotides (data not shown). When the cells were pre-
incubated with c-Jun/AP-1 inhibitor, curcumin (12.5 μ M),
for 15 min, the aldosterone-induced AP-1 activity was com-
pletely abolished (n=3, p<0.05, Fig. 3B). To examine whether
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0.05 vs. aldosterone-treated cells. In some experiments, the nuclear extracts from aldosterone-stimulated mesangial cells were pre-incu-
bated with or without an antibody to c-jun or c-fos for 1 hr at room temperature and were then analyzed for AP-1 binding activity. Pre-incu-
bation of nuclear extracts with c-jun or c-fos antibody induced supershift of aldosterone-induced AP-1 activity (upper panel). In both (A)
and (B) Left panel, the autoradiograph is a representative of five independent experiments with similar results. Right panel, the optical den-
sity of autoradiographic signals was quantified and calculated as the ratio of aldosterone-treated cells to untreated control. Results are ex-
pressed as fold increase over untreated control (represented as 1) in densitometric arbitrary units. Each value represents the mean±SEM.
(C) Inhibition of aldosterone-induced TGF-β 1 production by curcumin. Cells were pre-incubated with or without curcumin (12.5 μ M) for 15
min, and then incubated with aldosterone (5 ng/mL) for 24 hr and TGF-β 1 protein was measured by ELISA. *p<0.05 vs. untreated control.
� p<0.05 vs. aldosterone-treated cells.
Fig. 3. Role for AP-1 activation in the aldosterone-induced TGF-
β 1 expression. (A) Time course for AP-1 activation by aldosterone.
Cells were incubated with aldosterone (5 ng/mL) for the indi-
cated time points. AP-1 DNA binding activity in the nuclear ex-
tracts was measured by EMSA using AP-1 consensus oligonu-
cleotides. *p<0.05 vs. untreated control. (B) Inhibition of aldos-
terone-induced AP-1 activity by curcumin. Cells were pre-incu-
bated with or without AP-1 inhibitor, curcumin (12.5 μ M), for 15
min, and then stimulated with aldosterone (5 ng/mL) for 15 min,
and EMSA was performed. *p<0.05 vs. untreated control. 
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Caldosterone-induced activation of AP-1 is responsible for the
increased TGF-β 1 production, cells were pre-incubated with
curcumin (12.5 μ M) for 15 min and then were stimulated
with aldosterone (5 ng/mL) for 24 hr and TGF-β 1 was mea-
sured in the cell supernatants by ELISA. Curcumin completely
inhibited the aldosterone-induced TGF-β 1 production (n=
5, p<0.05, Fig. 3C). 
Role for JNK pathway in the aldosterone-induced TGF-
β β 1 expression
The activation of JNK has been shown to be linked to AP-
1 activity particularly to the phosphorylation of c-Jun (17).
We examined the phosphorylation of JNK in the cells stim-
ulated with aldosterone by western blot analysis. Aldosterone
(5 ng/mL) phosphorylated both 46 and 54 kDa JNKs in
mesangial cells from 2 to 10 min and the peak phosphory-
lation was seen at 10 min (n=5, p<0.05, Fig. 4A). When
the cells were pre-incubated with spironolactone (10-9 M)
and then stimulated with aldosterone, aldosterone-induced
JNK activity was significantly inhibited (n=5, p<0.05, Fig.
4B). When the cells were pre-incubated with JNK inhibitor,
SP600125 (20 μ M), and then stimulated with aldosterone
(5 ng/mL), aldosterone-induced TGF-β 1 protein production
was significantly inhibited (n=5, p<0.05, Fig. 4C). 
Role for ERK1/2 pathway in the aldosterone-induced
TGF-β β 1 expression
We examined the phosphorylation of ERK1/2 in the cells
stimulated with aldosterone by western blot analysis. Aldos-
terone (5 ng/mL) phosphorylated both 42 and 44 kDa ERK1/
2 in mesangial cells from 2 to 60 min and the peak phospho-
rylation was seen at 10 min (n=3, p<0.05, Fig. 5A). When
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Fig. 4. Role for JNK phosphorylation in the aldosterone-induced
TGF-β 1 expression. (A) Cells were incubated with aldosterone (5
ng/mL) for various time points, and phosphorylated JNK was detect-
ed by Western blot analysis. *p<0.05 vs. untreated control. (B) Inhi-
bition of aldosterone-induced JNK phosphorylation by spironolac-
tone. Cells were pre-incubated with or without spironolactone (10
-9
M) for 60 min, and then incubated with aldosterone (5 ng/mL) for 10
min, and western blot was performed. *p<0.05 vs. untreated con-
trol.
� p<0.05 vs. aldosterone-treated cells. In both (A) and (B) Upper
panel, the autoradiograph is a representative of five independent
experiments with similar results. Lower panel, the optical density of
autoradiographic signals was quantified and calculated as the ratio
of aldosterone-treated cells to untreated control. Results are exp-
ressed as fold increase over untreated control (represented as 1)
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in densitometric arbitrary units. Each value represents the mean±SEM. (C) Inhibition of aldosterone-induced JNK phosphorylation by
SP600125. Cells were pre-incubated with or without SP600125 (20 μ M) for 15 min, and then incubated with aldosterone (5 ng/mL) for 24
hr, and TGF-β 1 protein was measured by ELISA. *p<0.05 vs. untreated control. 
� p<0.05 vs. aldosterone-treated cells. the cells were pre-incubated with spironolactone and then
stimulated with aldosterone, aldosterone-induced ERK1/2
activity was significantly decreased (n=3, p<0.05, Fig. 5B).
In addition, when the cells were pre-incubated with ERK1/2
inhibitor, PD98059 (50 μ M), and then stimulated with aldos-
terone (5 ng/mL), aldosterone-induced TGF-β 1 protein pro-
duction was inhibited (n=5, p<0.05, Fig. 5C). 
DISCUSSION
In the present study, we demonstrated that aldosterone
stimulated TGF-β 1 expression in rat mesangial cells, partly
through the induction of ERK1/2 and JNK phosphorylation
and AP-1 DNA binding activity. These results suggested a
mechanism involved in the anti-fibrotic effect of spironolac-
tone which was demonstrated in the animal models of vari-
ous renal injury as well as human chronic kidney diseases.
In our study, aldosterone induced transcription factor, AP-
1 DNA binding activity, which led to TGF-β 1 up-regulation
in mesangial cells. Recently, the role of AP-1 activation in the
regulation of TGF-β 1 expression in mesangial cells has been
described in a few studies. A positive regulatory region in
TGF-β 1 5′ -flanking sequence, which is responsible for the in-
duction of TGF-β 1, has an AP-1 binding site. Oxidized LDL
has been shown to induce TGF-β 1 expression through the AP-
1 binding site (16). In a study done by Ahn et al. (18), trans-
fection of mesangial cells with AP-1 decoy oligodeoxynucl-
eotides strongly inhibited high glucose- and angiotensin II-
induced TGF-β 1 expression. In addition, administration of
AP-1 decoy oligodeoxynucleotides into streptozotocin-induced
diabetic rat kidney using the hemagglutinating virus of Japan-
liposome method also abolished TGF-β 1 and plasminogen
activator inhibitor-1 expression.
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Fig. 5. Role for ERK1/2 phosphorylation in aldosterone-induced
TGF-β 1 expression. (A) Cells were incubated with aldosterone (5
ng/ mL) for various time points, and phosphorylated ERK1/2 was
detected by Western blot analysis. *p<0.05 vs. untreated control.
(B) Inhibition of aldosterone-induced ERK1/2 phosphorylation by
spironolactone. Cells were pre-incubated with or without spirono-
lactone (10
-9 M) for 60 min, and then incubated with aldosterone
(5 ng/mL) for 10 min, and western blot was performed. *p<0.05 vs.
untreated control. 
� p<0.05 vs. aldosterone-treated cells. In both a
and b Upper panel, the autoradiograph is a representative of five
independent experiments with similar results. Lower panel, the opti-
cal density of autoradiographic signals was quantified and calcu-
lated as the ratio of aldosterone-treated cells to untreated control.
Results are expressed as fold increase over untreated control (rep-
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resented as 1) in densitometric arbitrary units. Each value represents the mean±SEM. (C) Inhibition of aldosterone-induced ERK1/2 phos-
phorylation by PD98059. Cells were pre-incubated with or without PD98059 (50 μ M) for 15 min, and then incubated with aldosterone (5 ng/
mL for 24 hr, and TGF-β 1 protein was measured by ELISA. *p< 0.05 vs. untreated control. 
� p<0.05 vs. aldosterone-treated cells.
p-ERK1/2
t-ERK1/2c-Jun contains a docking site for the JNK, which phos-
phorylate serines 63 and 73, thereby enhancing its transcrip-
tional potential and stability (19). Activation of JNK results
in greatly enhanced c-Jun transcriptional activity and induc-
tion of the AP-1 target gene (19). Most cells express two
JNK isoforms, 45 kDa and 54 kDa in size and termed
JNK1 and JNK2, which are highly similar in their modes
of regulation (20). In our study, aldosterone rapidly induced
phosphorylation of JNK and spironolactone abolished aldos-
terone-induced phosphorylation of JNK. In addition, both
JNK inhibitor, SP600125, and spironolactone suppressed
aldosterone-induced TGF-β 1 production, suggesting that
blocking JNK activation contributed to the inhibition of c-
jun/AP-1 activation, and finally TGF-β 1expression.
In our study, aldosterone rapidly stimulated ERK1/2 phos-
phorylation which led to subsequent increase in the TGF-β 1
production. Aldosterone-induced ERK1/2 activation has been
demonstrated in different in vitro and in vivo studies. Aldos-
terone-induced ERK1/2 activation has been shown to stim-
ulate collagen gene expression and synthesis in renal fibrob-
lasts (21) to induce mesangial cell proliferation (22), and to
increase mytogenic response synergistically with angiotensin
II in vascular smooth muscle cells (23). However, a direct
relationship between ERK1/2 activation and TGF-β 1 up-
regulation in mesangial cells has not been clearly determined.
In an animal study using aldosterone/salt-induced hyper-
tensive rats, chronic administration of spironolactone inhib-
ited ERK1/2 activity and suppressed expression of TGF-β 1,
type I and III collagen, and monocyte chemoattractant pro-
tein-1 mRNA, which resulted in the amelioration of perivas-
cular fibrosis and coronary microvascular hyperplasia (24).
However, a direct relationship between ERK1/2 activation
and TGF-β 1 up-regulation was not confirmed in that study.
Recently, the role for ERK1/2 in the stimulation of TGF-β 1
expression was demonstrated in two different cells. In a study
done by Huang et al. (25), renin induced rapid activation of
cellular ERK1/2 in rat mesangial cells and an ERK kinase
inhibitor significantly reduced the renin-induced ERK1/2
phosphorylation and the subsequent increase in TGF-β 1
mRNA expression. Otsuka et al. (26) has reported that
liposomes composed of phosphatidylserine activated ERK
which led to the expression of TGF-β 1 in macrophages. 
In summary, our data provide an evidence that aldosterone
stimulates TGF-β 1 expression in rat mesangial cells partly
by enhancing ERK1/2 and JNK activities and subsequent
AP-1 activity. This study also provides an understanding of
a part of intracellular mechanisms for proliferative and fibrot-
ic effect of aldosterone in the inflammatory renal diseases.
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